Precision For Medicine

K2 EDTA buffy coat samples.

K2 EDTA plasma biospecimen samples.

Customized tissue microarrays produced on demand, with each core individually selected by on-site, board-certified pathologists to support biomarker screening of frozen or formalin-fixed paraffin-embedded (FFPE) cohort specimens.

TMA samples from neoplastic, diseased, and normal tissues to meet specific research objectives.

Thousands of IRB-approved, clinically annotated biospecimens, including samples characterized via next-generation sequencing (NGS), available to help researchers optimize biomarker and diagnostic development.

Over 3 million FFPE samples and histology slides covering a full spectrum of oncologic and other medical diseases, obtained from certified laboratories and hospitals.

Leukopaks collected in a CLIA-certified donor center with in-house processing and shipping to ensure optimal cell viability and quality, providing up to 100x more cells from the same donor than PBMCs.

Viable cell products including isolated immune cells and PBMCs for cellular assays and immunology research.

Custom biospecimen procurement services providing ethically sourced and IRB-approved human research biospecimens tailored to specific protocol and study needs.

Mirrored twin biospecimens cut from the same tissue blocks that contributed to landmark projects from the Cancer Genome Atlas (TCGA), paired with biofluids.

Healthy and disease-state human peripheral blood mononuclear cells (PBMCs) sourced from donors, accompanied by characterization testing, demographic data, and clinical or molecular certification.

High-quality tissue specimens including FFPE and fresh frozen options from healthy and disease-state donors.

Retained diagnostic samples available for retrospective studies and assay validation.

Mirrored twin biospecimens from the Expression Project for Oncology (expO), providing exome-wide expression data and clinical annotations.

MIRROR (Matched & Integrated Repository for Rediscovered Oncology Research) is a novel oncology cohort derived from the matched twin tissue blocks of The Cancer Genome Atlas (TCGA) and the Expression Project for Oncology (expO), providing tissue, blood, and derivatives annotated with clinical and molecular context.

Frozen normal tissue biospecimens.

Healthy or disease-state peripheral blood mononuclear cells with >95% pre-freeze viability—HLA typed and viral negative.

Recently collected, data-rich specimens with exceptional quality and traceability spanning 50+ oncology and disease categories.

Custom collections of fresh, frozen, and fixed tissues from diseased and healthy subjects, with matched tissues and biofluids available for research.

Access tissue and biofluids from the donors who built TCGA and The Expression Project for Oncology (expO) with integrated multi-omic data.

Healthy and disease-state research-grade cell subsets purified within hours of collection.

Fresh leukopaks from HLA-typed donors providing up to 100x more cells from a single donor than whole blood collections.

Human blood, plasma, serum, CSF, stool, saliva, urine, ascites fluid, swabs, and more collected with storage and shipping temperature annotations.

Clinically annotated, high quality autoimmune biospecimens including DNA/RNA, PBMCs, blood, serum, plasma, tissue, and other biofluids collected from global partner sites to support autoimmune therapeutics and diagnostics research.

Whole blood combined with other biofluids or derivatives from the same participant.

Double or single spun human plasma available in all anticoagulants, single tube, bulk, or pooled, collected from normal healthy and disease-state consented donors.

COVID-19 specimens designed to meet research needs, housed in an on-site biorepository or prospectively collected from a network of global partner sites.

Fresh or cryopreserved leukopaks containing up to 10x more CD34+ stem cells from a single donor to reduce donor variability.

Other biologics available include saliva, swabs, urine, fecal, CSF, synovial fluid, and more.

High quality human bone marrow mononuclear cells collected from disease-state donors and healthy donors with longitudinal data, offering an excellent source of hematopoietic stem cells and biomarkers.

Clinically annotated, high quality infectious disease biospecimens and services to support the development of therapeutics and diagnostics.

Single cell suspensions dissociated from solid tumor via mechanical, enzymatic, or chemical dissociation techniques.

Streck DNA buffy coat samples.

Single tube, bulk, or pooled human serum, optimized for cell culture, assay validation, and in-vitro research.

Human whole blood products from a range of prescreened and qualified healthy and disease-state subjects.

Bone marrow mononuclear cells viably frozen in DMSO. Available with matched peripheral blood mononuclear cell, plasma, and BMA supernatant.

Standardized sample and PBMC processing services designed to safeguard biomarker assay data integrity through robust protocols, rapid turnaround times, and global laboratory capabilities.

Sophisticated solutions for immune cell profiling.

Support for diagnostic clinical trials including project planning, study design, collection procedures, and regulatory review.

Obtain a detailed molecular view into patient biology with a range of liquid biopsy analysis technologies, including our proprietary ApoStream platform which can isolate and enrich for circulating tumor cells for downstream analysis.

Custom kitting solutions designed to ensure accurate sample collection, labeling, and processing for clinical trials while maintaining sample integrity and full regulatory compliance.

Sophisticated solutions for circulating tumor cell liquid biopsy analysis.

In-house pathology team to provide expert assessments with rapid turn-around times, and sample processing services including FFPE and microdissection.

Developing and qualifying 2D and 3D human in vitro cell-based models, using a broad range of human primary cell types.

End-to-end single-cell sequencing solutions utilizing the 10x Genomics Chromium system and Illumina NGS platform.

Gene expression profiling of biopsies for tumor screening, therapeutic efficacy evaluation, mechanism of action illumination, and various other applications.

Specialty lab testing and support for diagnostic and CDx development from discovery through clinical trial assay development.

End-to-end immunohistochemistry solutions including kitting, sample logistics, staining via all major platforms, and in-house pathology services.

Automated multiplex immunofluorescence services that enable quantitative visualization of up to 9 markers in tissue and liquid biopsies.

Comprehensive genotyping solutions using the MassARRAY system for high-throughput analysis of genetic variations, ideal for applications in pharmacogenomics, oncology, and genetic research.

Development of multiplex FISH/ISH assays to detect abnormalities in a range of tissues, including hematological and solid organ tumors.

Cell sorter and flow cytometry system offering up to 18 parameters, up to 16 colors, and up to 5 lasers.

Get bioanalytical support for your biologic, cell therapy, gene therapy, or companion diagnostics program from the globally-recognized leaders in immunogenicity testing.